首页> 美国卫生研究院文献>Cardiovascular Diabetology >Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting

【2h】

Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting

机译：糖尿病患者冠状动脉支架置入术后糖化血红蛋白（HbA1c）水平和临床结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundDiabetes has been shown to be independent predictor of restenosis after percutaneous coronary intervention (PCI). The aim of the present study was to investigate whether a pre- and post-procedural glycaemic control in diabetic patients was related to major advance cardiovascular events (MACE) during follow up.

机译：背景技术已证明糖尿病是经皮冠状动脉介入治疗（PCI）后再狭窄的独立预测因子。本研究的目的是调查糖尿病患者术前和术后的血糖控制是否与随访期间的主要进展性心血管事件（MACE）有关。

著录项

期刊名称 Cardiovascular Diabetology
作者
Seyed Ebrahim Kassaian; Hamidreza Goodarzynejad; Mohammad Ali Boroumand; Mojtaba Salarifar; Farzad Masoudkabir; Mohammad Reza Mohajeri-Tehrani; Hamidreza Pourhoseini; Saeed Sadeghian; Narges Ramezanpour; Mohammad Alidoosti; Elham Hakki; Soheil Saadat; Ebrahim Nematipour;
展开▼
作者单位

展开▼
年(卷),期 2012(11),-1
年度 2012
页码 82
总页数 10
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Diabetes mellitus Percutaneous coronary intervention Glycaemic control Major adverse cardiovascular events;

机译：糖尿病;经皮冠状动脉介入治疗;血糖控制;重大不良心血管事件;

相似文献

外文文献
中文文献
专利

1. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting [J] . Seyed E Kassaian, Hamidreza Goodarzynejad, Mohammad A Boroumand, Cardiovascular Diabetology . 2012,第1期

机译：糖尿病患者冠状动脉支架置入术后糖化血红蛋白（HbA1c）水平和临床结果
2. Glycosylated hemoglobin (HBA1c) levels as follow-up for restenosis clinical outcomes after coronary artery stenting in patients with diabetes mellitus [J] . Suzy Fawzi The Egyptian Heart Journal . 2014,第1期

机译：糖化血红蛋白（HBA1c）水平作为糖尿病患者冠状动脉支架置入术后再狭窄临床结局的随访
3. Clinical influence of early follow-up glycosylated hemoglobin levels on cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction after coronary reperfusion [J] . Ahn Jinhee, Hong Taek Jong, Park Jin Sup, Coronary artery disease . 2015,第7期

机译：糖尿病冠状动脉再灌注ST段抬高型心肌梗死早期糖化血红蛋白水平的随访对心血管结局的临床影响
4. Clinical efficacy and safety of native bio-absorbable polymer Rapamycin-eluting stent (Excel stent) for Chinese patients with coronary artery disease [C] . Yanmin Xu, Guangping Li, Li Yin, International Congress on Coronary Artery Disease . 2009

机译：生物可吸收聚合物雷帕霉素洗脱支架（Excel支架）对冠心病患者的临床疗效和安全性
5. A comparison of the effects of treatment options for depression on glycosylated hemoglobin levels of a population of type 2 diabetics: A secondary data analysis. [D] . Ostrowski, MaryLynn. 2007

机译：抑郁症治疗选择对2型糖尿病人群糖基化血红蛋白水平的影响比较：二级数据分析。
6. Glycosylated hemoglobin levels and clinical outcomes in nondiabetic patients with coronary artery disease [O] . Jin Geng, Yanchun Zhang, Bingjian Wang, -1

机译：非糖尿病冠心病患者糖化血红蛋白水平和临床结局
7. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting [O] . Seyed Kassaian, Hamidreza Goodarzynejad, Mohammad Boroumand, 2012

机译：糖尿病患者冠状动脉支架置入术后糖化血红蛋白（HbA1c）水平和临床结果

Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting

摘要

著录项

相似文献

相关主题

期刊订阅